Product logins

Find logins to all Clarivate products below.


Cardiac Rhythm Management Devices | Market Insights | Europe | 2021

Although the COVID-19 pandemic will have a negative impact on procedure volumes and market growth in 2020, the European CRM device market will grow slowly overall over the forecast period. Increasing competition in the leadless pacemaker and S-ICD markets will result in falling prices and the availability of devices with improved quality. The emergence of smart modules for cardiac monitoring will bolster the ICM market.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the European cardiac rhythm management device market across a 10-year period.

Related Medtech Insights Reports

Report
Biosurgical Agents – Market Insights – Europe
The Europe biosurgical agent market will exhibit modest growth over the forecast period. This expansion will be fueled by a continued preference for biosurgical agents over alternative solutions,…
Report
Trauma Devices – Market Insights – Europe
Although financial constraints among European healthcare facilities and the rise of GPOs that will exert downward pressure on ASPs will limit the European trauma device market, favorable…
Report
Cardiac Rhythm Management Devices – Market Insights – United States
The US CRM device market is expected to grow rapidly through 2034, driven by the increasing adoption of innovative devices, such as dual-chamber leadless pacemakers and extravascular ICDs. These…
Report
Infusion Pumps – Market Insights – Europe
The European infusion pump demand will be underpinned by aging populations and rising chronic disease, while accelerating adoption of closed-loop, EHR-integrated smart pumps and growing demand of…
Report
Spinal Implants – Market Insights – Europe
The European spinal implant market will be characterized by modest growth, driven by demographic trends such as a rapidly aging population and the rising prevalence of spinal disorders. Adoption…